iNOS expression and nitrotyrosine formation in the myocardium in response to inflammation is controlled by the interferon regulatory transcription factor 1

Circulation

Volumn 96, Issue 2, 1997, Pages 585-591

  Bachmaier, Kurt ^b   Neu, Nikolaus ^b   Pummerer, Christian ^b   Duncan, Gordon S ^b   Mak, Tak W ^b   Matsuyama, Toshifumi ^b   Penninger, Josef M ^a  

^a UNIVERSITY OF TORONTO   (Canada)

^b NONE

Author keywords

Genes; Heart failure; Immunohistochemistry; Molecular biology; Myocarditis

Indexed keywords

3 NITROTYROSINE; NITRIC OXIDE; NITRIC OXIDE SYNTHASE; REGULATOR PROTEIN; TRANSCRIPTION FACTOR; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL MODEL; ARTICLE; AUTOIMMUNITY; CONTROLLED STUDY; DIAGNOSIS; ETIOLOGY; GENE TARGETING; HEART FAILURE; HUMAN; HUMAN CELL; IMMUNOHISTOCHEMISTRY; IMMUNOPATHOGENESIS; MOUSE; MYOCARDITIS; NONHUMAN; PHENOTYPE; PREVALENCE; PRIORITY JOURNAL; TRANSCRIPTION REGULATION;

ANIMALS; AUTOIMMUNITY; DNA-BINDING PROTEINS; GENE EXPRESSION REGULATION; HUMANS; IMMUNOHISTOCHEMISTRY; INFLAMMATION; INTERFERON REGULATORY FACTOR-1; MACROPHAGES; MICE; MICE, KNOCKOUT; MYOCARDITIS; MYOCARDIUM; NITRIC OXIDE SYNTHASE; PHOSPHOPROTEINS; TRANSCRIPTION FACTORS; TYROSINE;

EID: 0030811113     PISSN: 00097322     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (49)

1. Lowenstein CJ, Snyder SH. Nitric oxide, a novel biological messenger. Cell. 1992;70:705-707.
2. Nathan C. Nitric oxide as a secretory product of mammalian cells. FASEB J. 1992;6:3051-3064.
3. Moncada S, Palmer RMJ, Higgs EA. Nitric oxide: physiology, pathophysiology and pharmacology. Pharmacol Rev. 1991;43: 109-142.
4. Magrinat G, Mason SN, Shami PS, Weinberg JB. Nitric oxide modulation of human leukemia cell differentiation and gene expression. Blood. 1992;80:1880-1884.
5. Xie QW, Cho HJ, Calaycay J, Mumford RA, Swiderek KM, Lee TD, Ding A, Troso T, Nathan C. Cloning and characterization of inducible nitric oxide synthase from mouse macrophages. Science. 1992;256:225-228.
6. Lowenstein CJ, Glatt CS, Bredt DS, Snyder SH. Cloned and expressed macrophage nitric oxide synthase contrasts with the brain enzyme. Proc Natl Acad Sci U S A. 1992;89:6711-6715.
7. Balligand JL, Kelly RA, Marsden PA, Smith TW, Michel T. Control of cardiac muscle cell function by an endogenous nitric oxide signalling system. Proc Natl Acad Sci U S A. 1993;90:347-351.
8. Kamijo R, Shapiro D, Le J, Huang S, Aguet M, Vilcek J. Generation of nitric oxide and induction of major-histocompatibility complex class II antigen in macrophages from mice lacking the interferon γ receptor. Proc Natl Acad Sci U S A. 1993;90:6626-6630.
9. Ding AH, Nathan CF, Stuehr J. Release of reactive nitrogen intermediates and reactive oxygen intermediates from mouse peritoneal macrophages. J Immunol. 1988;141:2407-2412.
10. Finkel MS, Oddis CV, Jacob TD, Watkins SC, Hattler BG, Simmons RI. Negative inotropic effects of cytokines on the heart mediated by nitric oxide. Science. 1992;257:387-389.
11. Roberts AB, Vodovotz Y, Roche NS, Sporn MB, Nathan CD. Role of nitric oxide in antagonistic effects of transforming growth factor-beta and interleukin-1 beta on the beating rate of cultured cardiac myocytes. Mol Endocrinol. 1992;6:1921-1930.
12. Vodovotz Y, Bogdan C, Paik J, Xie QW, Nathan C. Mechanisms of suppression of macrophage nitric oxide release by transforming growth factor-beta. J Exp Med. 1993;178:605-613.
13. de-Belder AJ, Radomski MW, Why HJ, Richardson PJ, Bucknall CA, Salas E, Martin JF, Moncada S. Nitric oxide synthase activities in human myocardium. Lancet. 1993;341:84-85. See comments.
14. de-Belder AJ, Radomski MW, Why HJ, Richardson PJ, Martin JF. Myocardial calcium-independent nitric oxide synthase activity is present in dilated cardiomyopathy, myocarditis, and postpartum cardiomyopathy but not in ischaemic or valvar heart disease. Br Heart J. 1995;74:426-430.
15. de-Belder A, Moncada S. Cardiomyopathy: a role for nitric oxide? Int J Cardiol. 1995;50:263-268.
16. Haywood GA, Tsao PS, Vonderleyen HE, Mann MJ, Kelling PJ, Trindade PT, Lewis NP, Byrne CD, Rickenbacher PR, Bishopric NH, Cooke JP, McKenna WJ, Fowler MB. Expression of inducible nitric-oxide synthase in human heart-failure. Circulation. 1996;93: 1087-1094.
17. Habib FM, Springall DR, Davies GJ, Oakley CM, Yacoub MH, Polak JM. Tumor-necrosis-factor and inducible nitric-oxide synthase in dilated cardiomyopathy. Lancet. 1996;347:1151-1155.
18. Brady AJ, Warren JB, Poole-Wilson PA, Williams TJ, Harding SE. Nitric oxide attenuates cardiac myocyte contraction. Am J Physiol. 1993;265:H176-H182.
19. 2+-independent nitric oxide synthase in the myocardium. Br J Pharmacol. 1992;105:575-580.
20. Huber SA. Viral myocarditis: a tale of two diseases. Lab Invest. 1992;66:1-3.
21. Rose NR, Herskowitz A, Neumann DA, Neu N. Autoimmune myocarditis: a paradigm of post-infection autoimmune disease. Immunol Today. 1988;9:117-120.
22. Neu N, Rose NR, Beisel KW, Herskowitz A, Gurri-Glass G, Craig SW. Cardiac myosin induces myocarditis in genetically predisposed mice. J Immunol. 1987;139:3630-3636.
23. Smith SC, Allen PM. Myosin-induced acute myocarditis is a T cell-mediated disease. J Immunol. 1991;147:2141-2147.
24. Penninger JM, Neu N, Timms E, Wallace VA, Koh DR, Kishihara K, Pummerer C, Mak TW. Induction of experimental autoimmune myocarditis in mice lacking CD3 or CD8 molecules. J Exp Med. 1993;178:1837-1842.
25. McCartney-Francis NJ, Allen B, Mizel DE, Albina JE, Xie QW, Nathan CF, Wahl SM. Suppression of arthritis by an inhibitor of nitric oxide synthase. J Exp Med. 1993;178:749-754.
26. g-monomethyl-L-arginine. J Exp Med. 1994;179:651-660.
27. Lin RF, Lin TS, Tilton RG, Cross AH. Nitric oxide localized to spinal cords of mice with experimental allergic encephalomyelitis: an electron paramagnetic resonance study. J Exp Med. 1993;178: 643-648.
28. Kolb H, Kolb-Bachofen V. Type 1 (insulin-dependent) diabetes mellitus and nitric oxide. Diabetologia. 1992;35:796-797.
29. Kleemann R, Rothe H, Kolb-Bachofen V, Xie QW, Nathan C, Martin S, Kolb H. Transcription and translation of inducible nitric oxide synthase in the pancreas of prediabetic BB rats. FEBS Lett. 1993; 328:9-12.
30. Matsuyama T, Kimura T, Kitagawa M, Pfeffer K, Kawakami T, Watanabe N, Kündig TM, Amakawa R, Kishihara K, Wakeham A, Potter J, Furlonger CL, Narendran A, Suzuki H, Ohashi PS, Paige CJ, Taniguchi T, Mak TW. Targeted disruption of IRF-1 or IRF-2 results in abnormal type I IFN gene induction and aberrant lymphocyte development. Cell. 1993;75:83-97.
31. Neu N, Beisel KW, Traystman MD, Rose NR, Craig SW. Autoantibodies specific for the cardiac myosin isoform are found in mice susceptible to coxsackievirus B3-induced myocarditis. J Immunol. 1987;138:2488-2492.
32. Pummerer C, Berger P, Frühwirth M, Öfner C, Neu N. Cellular infiltrate, major histocompatibility antigen expression and immunopathogenic mechanisms in cardiac myosinCrossed D signinduced myocarditis. Lab Invest. 1991;65:538-547.
33. Vodovotz Y. Modified microassay for serum nitrite and nitrate. Biotechniques. 1996;20:390-394.
34. Horackova M, Armour JA, Hopkins DA, Huang MH. Nitric-oxide modulates signaling between cultured adult peripheral cardiac neurons and cardiomyocytes. Am J Physiol. 1995;269:C504-C510.
35. Ungureanu-Longrois D, Balligand JL, Kelly RA, Smith TW. Myocardial contractile dysfunction in the systemic inflammatory response syndrome: role of a cytokine-inducible nitric-oxide synthase in cardiac myocytes. J Mol Cell Cardiol. 1995;27:155-167.
36. Oury TD, Tatro L, Ghio AJ, Piantadosi CA. Nitration of tyrosine by hydrogen peroxide and nitrite. Free Radic Res. 1995;23:537-547.
37. Ischiropoulos H, al-Mehdi AB. Peroxynitrite-mediated oxidative protein modifications. FEBS Lett. 1995;364:279-282.
38. Haddad IY, Pataki G, Hu P, Galliani C, Beckman JS, Matalon S. Quantitation of nitrotyrosine levels in lung sections of patients and animals with acute lung injury. J Clin Invest. 1994;94:2407-2413.
39. Beckmann JS, Ye YZ, Anderson PG, Chen J, Accavitti MA, Tarpey MM, White CR. Extensive nitration of protein tyrosines in human atherosclerosis detected by immunohistochemistry. Biol Chem Hoppe-Seyler. 1994;375:81-88.
40. Bachmaier K, Pummerer C, Shahinian A, Ionescu J, Neu N, Mak TW, Penninger JM. Induction of autoimmunity in the absence of CD28 costimulation. J Immunol. 1996;157:1752-1757.
41. Kamijo R, Harada H, Matsuyama T, Bosland M, Gerecitano J, Shapiro D, Le J, Koh SI, Kimura T, Green SJ, Mak TW, Taniguchi T, Vilcek J. Requirement for transcription factor IRF-1 in NO synthase induction in macrophages. Science. 1994;263:1612-1615.
42. Lowenstein CJ, Alley EW, Raval P, Snowman AM, Snyder SH, Russel SW, Murphy WJ. Macrophage nitric oxide synthase gene: two upstream regions mediate induction by interferon-gamma and lipopolysaccharide. Proc Natl Acad Sci U S A. 1993;90:9730-9734.
43. Xie QW, Whisnant R, Nathan C. Promoter of the mouse gene encoding calcium-independent nitric oxide synthase confers inducibility by interferon γ and bacterial lipopolysaccharide. J Exp Med. 1993; 177:1779-1784.
44. Tanaka N, Kawakami T, Taniguchi T. Recognition DNA sequences of interferon regulatory factor 1 (IRF-1) and IRF-2, regulators of cell growth and the interferon system. Mol Cell Biol. 1993;13: 4531-4538.
45. Balligand JL, Kobzik L, Han X, Kaye DM, Belhassen L, O'Hara DS, Kelly RA, Smith TW, Michel T. Nitric oxide-dependent parasympathetic signaling is due to activation of constitutive endothelial (type III) nitric oxide synthase in cardiac myocytes. J Biol Chem. 1995; 270:14582-14586.
46. Ungureanu-Longrois D, Balligand JL, Simmons WW, Okada I, Kobzik L, Lowenstein CJ, Kunkel SL, Michel T, Kelly RA, Smith TW. Induction of nitric-oxide synthase activity by cytokines in ventricular myocytes is necessary but not sufficient to decrease contractile responsiveness to beta-adrenergic agonists. Circ Res. 1995;77: 494-502.
47. Nicholson S, da Glória Bonecini-Almeida M, Lapa e Silva JR, Nathan C, Xie QW, Mumford R, Weidner JR, Calaycay J, Geng J, Boechat N, Linhares C, Rom W, Ho JL. Inducible nitric-oxide synthase in pulmonary alveolar macrophages from patients with tuberculosis. J Exp Med. 1996;183:2293-2302.
48. Kodama M, Hanawa H, Saeki M, Hosono H, Inomata T, Suzuki K, Shibata A. Rat dilated cardiomyopathy after autoimmune giant cell myocarditis. Circ Res. 1994;75:278-284.
49. Rose NR. Myocarditis: from infection to autoimmunity. Immunologist. 1996;4:67-75.